COMP <GO>
BEAM vs JNJ // GROSS PROFIT MARGIN
Beam Therapeutics Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: BEAM 2
— JNJ 7
■ METRIC PARITY
LAST: $28.84 (+0.21%) • MKT CAP: $2.98B
gross-margins
—
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BEAM VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BEAM | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 67.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.10% | 25.50% | -57.60 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.09% | 2.97% | -15.06 | JNJ | /fcf-yield <GO> |
| Operating Margin | -60.00% | 34.70% | -94.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -57.20% | 28.50% | -85.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 120.00% | 6.00% | +114.00 | BEAM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.00 | 5.59 | +0.41 | BEAM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.7 | 62.1 | -4.41 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.98B | $662.49B | -$659.51B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BEAM REV | JNJ REV | BEAM GROSS % | JNJ GROSS % | BEAM FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $139.7M | $94.19B | — | 67.9% | -$360.0M | $19.70B |
| FY 2024 | $63.5M | $88.82B | — | 69.1% | -$356.2M | $19.84B |
| FY 2023 | $377.7M | $85.16B | — | — | -$149.2M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BEAM // BETA —
JNJ // BETA 1.08